Fulgent Genetics Inc (FLGT)
74.64
+1.63 +2.23%
NASDAQ
May 7, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 421.71M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 8.19 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 214.31M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 82.45% |
| Profit Margin (Quarterly) | 56.38% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 2.164B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 4.197 |
| PE Ratio | 9.114 |
| Price to Book Value | 3.800 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.0264 |
| Free Cash Flow (Quarterly) | 110.46M |
| Return on Equity | Upgrade |
View All FLGT News
News
-
WireHeadlineTime (ET)
-
MT Newswires05/07 13:14
-
SA Breaking News05/07 08:25
-
Yahoo05/07 06:08
-
Yahoo05/07 01:31
-
MT Newswires05/06 16:26
-
SA Breaking News05/06 16:09
-
Yahoo05/06 16:05
-
Yahoo05/06 14:45
-
SA Breaking News05/06 10:37
-
Yahoo05/06 08:00
-
SA Breaking News05/05 17:35
-
Yahoo05/05 13:28
-
Yahoo04/30 09:26
-
Yahoo04/28 12:16
-
Yahoo04/27 06:24
-
Yahoo04/24 06:35
-
Yahoo04/23 03:03
-
Yahoo04/22 07:01
-
Yahoo04/22 06:20
-
Yahoo04/20 07:21
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 08/04/2021 00:00 | Earnings Results | Q2 2021 Earnings Results |
| 08/04/2021 16:30 | Earnings Calls | Q2 2021 Earnings Call |
| 05/06/2021 00:00 | Earnings Results | Q1 2021 Earnings Results |
| 05/06/2021 16:30 EDT | Earnings Calls | Q1 2021 Earnings Call |
| 03/04/2021 00:00 | Earnings Results | Q4 2020 Earnings Results |
| 03/04/2021 16:30 EST | Earnings Calls | Q4 2020 Earnings Call |
| 11/09/2020 00:00 | Earnings Results | Q3 2020 Earnings Results |
| 11/09/2020 16:30 EST | Earnings Calls | Q3 2020 Earnings Call |
| 08/04/2020 16:30 EDT | Earnings Calls | Q2 2020 Earnings Call |
| 08/04/2020 00:00 | Earnings Results | Q2 2020 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; Canada; and Other Countries.
- URL: https://www.fulgentgenetics.com
- Investor Relations URL: https://fulgentgenetics.gcs-web.com
- HQ State/Province: California
- Sector: Healthcare
- Industry: Diagnostics & Research
- Equity Style: Small Cap/Growth
- Next Earnings Release: Aug. 04, 2021
- Last Earnings Release: May. 06, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 74.64 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| RFIMX | Ranger Micro Cap Institutional | 6.83% |
| FJSUQX | FT Top Picks December 2020 RE | 4.70% |
| PTH | Invesco DWA Healthcare Momentum ETF | 3.61% |
| RYWCX | Rydex S&P SmallCap 600 Pure Growth C | 2.50% |
| AFDVX | Applied Finance Explorer Investor | 2.04% |
| RZG | Invesco S&P SmallCap 600® Pure Gr ETF | 1.98% |
| DWAS | Invesco DWA SmallCap Momentum ETF | 1.10% |
| HIL259 | Hillsdale US Small Cap EqSrs Z CA$ U$H (USD) | 1.07% |
| SSMEX | Crossmark Steward Sm-Md Cp Enh Idx C | 0.53% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- FLGT Tweets Stocktwits
Advertisement
